Poster: HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)
作者
Carmelo Carlo‐Stella,Stephen Maxted Ansell,Pier Luigi Zinzani,John A. Radford,Kami J. Maddocks,Antonio Ventura Pinto,Graham P. Collins,Veronika Bachanová,Nancy L. Bartlett,Isabelle Bence‐Bruckler,Mehdi Hamadani,Justin Paul Kline,Jiřı́ Mayer,Kerry J. J. Savage,Ranjana H. Advani,Paolo Fabrizio Caimi,Olivier Casasnovas,Tatyana A. Feldman,Brian T. Hess,Mariana Bastos‐Oreiro